NCT07204470

Brief Summary

This study is designed to test the hypothesis that whole-grain forms of maize meal enhance and prolong satiety post-meal consumption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2025

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 17, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 2, 2025

Completed
Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

25 days

First QC Date

September 17, 2025

Last Update Submit

April 16, 2026

Conditions

Keywords

whole grainappetiteglycemic indexleptinghrelin

Outcome Measures

Primary Outcomes (5)

  • Satiety -Appetite

    Self-reported appetite ratings using a 100 mm visual analog scale (VAS) questionnaire with 3 items: desire to eat rated from very weak to very strong, hunger rated from not at all to extremely, and fullness rated from not at all to extremely.

    On each of four testing days, in fasted state, immediately after the standardised breakfast (0), and at 120 and 240 min after the breakfast

  • Satiety -Biomarkers: Leptin

    Blood by venipuncture to measure the appetite-regulating hormone leptin in nanograms per milliliter

    On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  • Satiety -Biomarkers: Ghrelin

    Blood by venipuncture to measure the appetite-regulating hormone ghrelin in picograms per milliliter

    On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  • Satiety - glycaemic parameters: Glucose

    Blood samples obtained by venipuncture in millimoles per liter

    On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  • Satiety - glycaemic parameters: Insulin

    Serum samples obtained by venipuncture in microunits per milliliter

    On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

Secondary Outcomes (5)

  • Anthropometric measurements - BMI

    Test Day 1 only prior to porridge consumption

  • Anthropometric measurements - WHR

    Test Day 1 only prior to porridge consumption

  • Anthropometric measurements - Fat Mass

    Test Day 1 only prior to porridge consumption

  • Dietary intake habits-QFFQ

    The protocol allows for completion prior to the first test day, or instead at any one of the four test days. There is no particular time point requirement that it be done at baseline nor within a certain window after test meal consumption.

  • Dietary intake habits-24 hour recall

    Completed at each of the four test days. There is no particular time point requirement that it be done at baseline nor within a certain window after test meal consumption.

Study Arms (4)

Whole grain maize porridge prepared with cold water

EXPERIMENTAL

White Star Whole Grain Instant Maize Porridge Original

Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

Whole grain maize porridge prepared with hot water

EXPERIMENTAL

White Star Whole Grain Instant Maize Porridge Original

Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

Smart Food

EXPERIMENTAL

FUTURELIFE Smart Food Original

Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

Instant Maize Porridge - reduced sugar formulation (WSIP)

EXPERIMENTAL

White Star Instant Maize Porridge Original- reduced sugar formulation (WSIP)

Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

Interventions

Cereal is in porridge form. One 350 ml bottle of water provided for the 4 hour test period 7:00-11:00 a.m.. Control dinner meal consumed the prior evening, then fast 10 hours overnight before visiting the test facility on four test days one week apart.

Instant Maize Porridge - reduced sugar formulation (WSIP)Smart FoodWhole grain maize porridge prepared with cold waterWhole grain maize porridge prepared with hot water

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Availability to participate on the test days
  • Interest and consent to participate in the study
  • Participants must be willing to fast 10 hours overnight before the test breakfast meal (only water allowed)
  • Products and meals high in fiber, alcohol and strenuous exercise should be avoided 24 hours before the test
  • Age 18-35 years
  • Healthy BMI: 18.5-24.9 kg/m2
  • Equal split, males and females

You may not qualify if:

  • Pregnancy; breast-feeding
  • History of gastrointestinal disease having an impact on food absorption or digestion; anorexia nervosa or bulimia nervosa
  • Anaemia
  • Hypoglycaemia
  • Cardiovascular disease; elevated plasma glucose; unstable thyroid function
  • Abnormal/irregular menstrual cycle
  • Substance abuse
  • Being on medication which influences appetite
  • Depression; smoking
  • Participation in any weight altering program; weight gain or loss \> 5 kg in 3 months prior to enrolment
  • History of intestinal discomfort when consuming relatively small (e.g., \<10g) amounts of non-digestible fibres
  • Any known food allergies or intolerances such as wheat or soy; special diets prescribed by medical practitioner
  • Any intensive physical training program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U. Pretoria

Pretoria, 0083, South Africa

Location

Study Officials

  • Henrietta L de Kock

    U Pretoria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2025

First Posted

October 2, 2025

Study Start

July 21, 2025

Primary Completion

August 15, 2025

Study Completion

August 15, 2025

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations